Anzeige
Mehr »
Donnerstag, 15.05.2025 - Börsentäglich über 12.000 News
Verpasst du gerade die Buffett-Aktie der neuen Generation?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2JJ99 | ISIN: US04962H5063 | Ticker-Symbol: YAG2
Frankfurt
15.05.25 | 08:06
0,905 Euro
+16,32 % +0,127
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
ATOSSA THERAPEUTICS INC Chart 1 Jahr
5-Tage-Chart
ATOSSA THERAPEUTICS INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,8930,92116:32
0,8930,92116:32

Aktuelle News zur ATOSSA THERAPEUTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiAtossa Therapeutics Inc: Atossa Therapeutics Announces Full Results from I-SPY 2 Endocrine-Optimization Sub-Study Evaluating Low-Dose (Z)-Endoxifen113Feasibility endpoint achieved; rapid Ki-67 suppression and substantial MRI-confirmed tumor shrinkage observed with favorable safety profile SEATTLE, May 14, 2025 /PRNewswire/ -- Atossa Therapeutics...
► Artikel lesen
DiAtossa Therapeutics GAAP EPS of -$0.05 beats by $0.014
DiATOSSA THERAPEUTICS, INC. - 10-Q, Quarterly Report3
DiATOSSA THERAPEUTICS, INC. - 8-K, Current Report1
ATOSSA THERAPEUTICS Aktie jetzt für 0€ handeln
DiAtossa Therapeutics Inc: Atossa Therapeutics Announces First Quarter 2025 Financial Results and Provides a Corporate Update93Announced strategic plan to advance (Z)-endoxifen for metastatic breast cancer indication Enhanced (Z)-endoxifen intellectual property portfolio with three new...
► Artikel lesen
05.05.RedChip Companies, Inc.: Atossa Therapeutics and Ainos Interviews Aired on the RedChip Small Stocks, Big Money Show on Bloomberg TV277ORLANDO, FL / ACCESS Newswire / May 5, 2025 / RedChip Companies aired interviews with Atossa Therapeutics, Inc. (Nasdaq:ATOS) and Ainos, Inc. (Nasdaq:AIMD) on the RedChip Small Stocks, Big Money show...
► Artikel lesen
30.04.Atossa wins U.S. patent related to multiple formulation of lead asset5
30.04.Atossa Therapeutics secures new patent for breast cancer drug7
30.04.Atossa Therapeutics, Inc.: Atossa Therapeutics Announces Issuance of U.S. Patent No. 12,281,056, Including 58 Claims Covering Various Formulations for its (Z)-endoxifen Portfolio103SEATTLE, April 30, 2025 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative medicines for breast...
► Artikel lesen
29.04.Atossa stellt Phase-3-Studie zur Brustkrebsprävention vor11
29.04.Atossa outlines phase 3 trial for breast cancer prevention2
29.04.Atossa Therapeutics, Inc.: Atossa Therapeutics Proposes Potentially Groundbreaking Study Aimed at Reducing Interval Breast Cancer in High-Risk Women at AACR 2025 157SEATTLE, April 29, 2025 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative medicines for breast...
► Artikel lesen
22.04.Atossa Therapeutics sichert neues Patent für Brustkrebsbehandlung29
22.04.Atossa Therapeutics secures new patent for breast cancer treatment4
22.04.Atossa Therapeutics announces issuance of U.S. patent3
22.04.Atossa Therapeutics, Inc.: Atossa Therapeutics Announces Issuance of U.S. Patent No. 12,275,684, Further Strengthening (Z)-endoxifen Portfolio161SEATTLE, April 22, 2025 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative medicines for breast...
► Artikel lesen
14.04.Nona Biosciences and Atossa team up to discover breast cancer therapies9
10.04.Nona Biosciences Inks Research Partnership With Atossa Therapeutics For Next-gen Breast Cancer Drugs9
10.04.Nona Biosciences and Atossa Therapeutics Partner to Discover Next-Generation Antibody Therapies for Breast Cancer154CAMBRIDGE, Mass., April 10, 2025 /PRNewswire/ -- Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to ITM)...
► Artikel lesen
07.04.ATOSSA THERAPEUTICS, INC. - 8-K, Current Report2
Seite:  Weiter >>
57 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,11